NM-001
NM-001 is a theranostic prodrug that targets ανβ3 integrin. NM-001 consists of cRGD and GFLG peptides, a DCM fluorophore and Chlorambucil (HY-13593). NM-001 internalizes into lysosomes of tumor cells via the cRGD peptide, and generates NM-002 (HY-178820) and Chlorambucil through intracellular cleavage at the GFLG peptide by overexpressed Cathepsin B (CTSB). NM-001 exhibits green fluorescence under physiological conditions, and converts to NIR fluorescence by CTSB activation. NM-001 has significant antitumor activity with low toxicity in HeLa cell xenografts mouse models. NM-001 can be used for real-time drug release monitoring research.
For research use only. We do not sell to patients.
- Formula: C105H131Cl3N20O21
- Molecular Weight:2115.64
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Chemical Information
-
Molecular Weight 2115.64
-
Formula C105H131Cl3N20O21
-
SMILES
CC(C1=C(OCCOCCOCCOCCN2C=C(N=N2)CCC(NCCCC[C@@H]3NC([C@H](NC([C@@H](NC(CNC([C@@H](NC3=O)CCCNC(N)=N)=O)=O)CC(O)=O)=O)CC(C=C4)=CC=C4O)=O)=O)C=C(OC(/C=C/C5=CC(Cl)=C(OCC6=CC=C(NC(CNC([C@@H](CC(C)C)NC([C@@H](CC7=CC=CC=C7)NC(CN)=O)=O)=O)=O)C=C6)C(COC(CCCC8=CC=C(N(CCCl)CCCl)C=C8)=O)=C5)=C/C9=C(C#N)\C#N)C9=C1)(C)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Subcutaneous Cell-Line-Derived Xenograft
Subcutaneous cell-line-derived xenograft (CDX) models are established by implanting cultured human cancer cell lines into immunodeficient mice, where the injected cells form localized tumors that can be monitored in vivo as a measure of tumorigenic potential, growth kinetics, and treatment response. These models are widely used in oncology research because they allow reproducible tumor formation and enable comparative assessment of tumor growth between different cell lines or genetic manipulations in a controlled in vivo microenvironment. Subcutaneous implantation of cancer cells in immunodeficient mice is a standard approach for evaluating tumor growth behavior and therapeutic response across multiple cancer types, including prostate, esophageal, pancreatic, and colon cancer models.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)